Evaluation of in vitro drug-drug interactions of ivermectin and antimalarial compounds. [PDF]
Tipthara P +3 more
europepmc +1 more source
The effect of phenobarbitone on the incorporation of delta-aminolaevulinic acid into rat liver microsomes [PDF]
R. Colin Garner, A.E.M. McLean
openalex +1 more source
ABSTRACT A physiologically based pharmacokinetic (PBPK) model was developed and verified for dordaviprone, a small molecule with antitumor effects in glioma patients. The model was applied to assess the drug–drug interaction (DDI) potential of dordaviprone as a victim of CYP3A4 inhibitors and inducers, and as a perpetrator of CYP3A4, CYP2C8, CYP2D6 ...
Swati Jaiswal +6 more
wiley +1 more source
NAD(P)<sup>+</sup>-dependent alcohol oxidoreductases oxidize 7-hydroxycannabidiol to a reactive formyl metabolite. [PDF]
Wu Q +4 more
europepmc +1 more source
The Composition of Liver Vitamin A Ester and the Synthesis of Vitamin A Ester by Liver Microsomes
Sidney Futterman, John S. Andrews
openalex +1 more source
Human in vitro metabolism of an environmental mixture of polycyclic aromatic hydrocarbons (PAH) found at the Portland Harbor Superfund Site. [PDF]
Gaither KA +4 more
europepmc +1 more source
The role of endogenous cations in the Na+-K+-Mg2+-effected adenosine triphosphatase of cerebral microsomes [PDF]
Peter S. Goldfarb, Richard Rodnight
openalex +1 more source
ABSTRACT Valemetostat tosylate (valemetostat) is an oral, potent, selective dual inhibitor of enhancer of zeste homolog (EZH)2 and EZH1, approved in Japan for the treatment of relapsed/refractory adult T‐cell leukemia/lymphoma and peripheral T‐cell lymphoma.
Akiko Watanabe +6 more
wiley +1 more source
Protocol for screening inhibitors of the fungal sphingolipid-metabolizing enzyme ceramide synthase. [PDF]
Zhong A +4 more
europepmc +1 more source

